Treat the disease
Pro Research Analysisby 
Searched over 200M research papers
Treating Diseases: Insights from Recent Research
Treat-to-Target Strategy in Systemic Lupus Erythematosus (SLE)
SLE Treatment Recommendations
The treat-to-target (T2T) approach has been successfully applied to various diseases, including systemic lupus erythematosus (SLE). An international task force comprising specialists from multiple disciplines developed recommendations to improve SLE management. The primary goals include targeting remission, preventing damage, and enhancing the quality of life for patients. These recommendations were based on systematic literature reviews and expert consensus, achieving high levels of agreement among the task force members.
Dietary Management in Crohn's Disease
CD-TREAT Diet
Exclusive enteral nutrition (EEN) is a well-established dietary treatment for Crohn's disease (CD), but its acceptability is limited. A novel food-based diet, CD-TREAT, has been developed to replicate the effects of EEN. Studies have shown that CD-TREAT is easier to comply with and induces similar beneficial changes in the gut microbiome and inflammation levels as EEN. In clinical trials, CD-TREAT led to significant improvements in clinical activity and inflammation markers in children with active CD.
Treat-to-Target in Crohn's Disease
The traditional step-wise treatment approach for Crohn's disease often fails to improve long-term outcomes. A treat-to-target strategy, which involves regular assessment of disease activity and subsequent treatment adjustments, has been proposed to address this issue. This approach aims to minimize disease activity early, limit progression, and improve long-term outcomes by targeting mucosal healing and inflammation rather than just symptoms .
Rheumatoid Arthritis (RA) Management
Updated Treat-to-Target Recommendations
The treat-to-target strategy has significantly improved outcomes for patients with rheumatoid arthritis (RA). The 2014 update of the recommendations emphasizes the importance of achieving remission or low-disease activity. The updated guidelines highlight the role of comorbidities and the necessity of regular follow-ups with therapeutic adjustments based on composite measures of disease activity. Shared decision-making with patients is also a key component of these recommendations.
Alzheimer's Disease (AD) Treatment
Pharmacologic and Non-Pharmacologic Approaches
Alzheimer's disease (AD) management focuses on enhancing autonomy, functional abilities, and quality of life for patients and caregivers. Cholinesterase inhibitors, such as tacrine and donepezil, are commonly used to treat cognitive symptoms. Newer agents and non-pharmacologic measures, including support groups, are also important in managing behavioral and psychiatric symptoms. Research is ongoing to develop disease-modifying treatments targeting specific aspects of AD pathology, such as amyloid-beta aggregation .
Alternative Therapies in Adult-onset Still's Disease (AOSD)
Chinese Herbal Medicine
Adult-onset Still's disease (AOSD) is a rare systemic autoinflammatory disease. Traditional treatments include non-steroidal anti-inflammatory drugs and glucocorticoids, which can have significant side effects. A case report demonstrated the successful use of Chinese herbal medicine (CHM) in treating AOSD, leading to rapid remission and sustained improvement over a 15-month follow-up period. This suggests that CHM could be a viable complementary therapy for AOSD, although further studies are needed to confirm its efficacy.
Conclusion
The treat-to-target strategy has shown promise in managing various diseases, including SLE, Crohn's disease, and RA, by focusing on specific therapeutic goals and regular monitoring. Dietary interventions like CD-TREAT offer new avenues for managing Crohn's disease, while alternative therapies such as Chinese herbal medicine provide additional options for conditions like AOSD. In Alzheimer's disease, a combination of pharmacologic and non-pharmacologic approaches remains essential for improving patient outcomes. Continued research and updated guidelines are crucial for optimizing treatment strategies across these conditions.
Sources and full results
Most relevant research papers on this topic